In 1983 it was shown that intranasal glucagon raises blood glucose, and in 1989 it was shown that nasal glucagon is as effective as IM glucagon in the treatment of spontaneous hypoglycemia in adults; later it was shown that intranasal glucagon is effective in insulin-induced hypoglycemia in children and in adults [9]. The gene discussed is INS; the disease is Hypoglycemia.